Grifols (GIFLF) Interest Coverage Ratio Growth (1y) (2011 - 2025)
Powered by 
Analysis
Grifols (GIFLF) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 36.43% |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -532.04% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -60.78% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 176.09% |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 1,170.12% |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 19.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -19.13% |
| Dec 31, 2021 | 19.04% |
| Dec 31, 2020 | -104.54% |
| Dec 31, 2019 | 6,005.27% |
| Dec 31, 2018 | 75.26% |
| Jun 30, 2018 | -130.78% |
| Dec 31, 2017 | 59.90% |
| Jun 30, 2017 | 13.92% |
| Dec 31, 2016 | -150.65% |
| Sep 30, 2016 | -4.32% |
| Jun 30, 2016 | -9.97% |
| Dec 31, 2015 | 42.40% |
| Sep 30, 2015 | 2.69% |
| Jun 30, 2015 | 10.05% |
| Mar 31, 2015 | -211.77% |
| Dec 31, 2014 | 198.73% |
| Sep 30, 2014 | 24.00% |
| Jun 30, 2014 | 19.31% |
| Mar 31, 2014 | 9.61% |
| Dec 31, 2013 | 2.36% |